This #PancreaticCancerAwareness month, we highlight the KPC cell line – helping scientists’ study pancreatic tumours more accurately and develop new therapies. Developed by Prof. @jen_morton from @CRUK_SI and made globally accessible by @CancerToolsOrg . Learn more at cancertools.org/advancing-panc…
#CancerResearch

We’re excited to exhibit at the 67th ASH Annual Meeting, 6–8 Dec 2025!

📍 Booth #783 — come meet the team and explore our researcher-developed preclinical models, from treatment-resistant myeloma cell lines to CD marker antibodies.

As part of @CR_UK - we champion open, o accelerate blood cancer research worldwide. Have models in leukaemia, lymphoma, myeloma or other blood cancers? Let’s connect!

See you at #ASH2025 — or learn more about us here: cancertools.org/about/

#CancerResearch #BloodCancerResearch #BloodCancer #Myeloma #Leukaemia

We’re exhibiting at #SITC25! 🎉Join @CancerToolsOrg at the Society for Immunotherapy of Cancer Annual Meeting on Nov 7–8 at Booth #924 in National Harbor, MD 🇺🇸
Meet our team, explore researcher-developed tools, and discover how we’re driving cancer drug discovery.🔗 lnkd.in/eWqRcDxb

We’re live at @ELRIG_SCIENCE DrugDiscovery2025!
Meet the @CancerToolsOrg team at Booth B30 as we connect with scientists and innovators shaping the future of cancer research.
Discover how our cell lines, antibodies & PDX models are accelerating global cancer discoveries.

#EL#OpenScience #CancerTools #OncologyResearch

🕕 Less than a week until #ELRIGDD25!

Join CancerTools.org at Booth B30 to explore 1,500+ human & animal cancer cell lines powering global drug discovery, many developed with our partner @CR_UK

📅 21–22 Oct 2025 | 📍 Liverpool, UK
🌐 cancertools.org
#Drurch

📢 Excited to announce we’ll be at #ELRIGDD25!

📅 21–22 Oct 2025 | 📍 Booth B30, Liverpool, UK

Visit @CancerToolsOrg – home to 1,500+ trusted cancer research cell lines (including BICR, KPC, PEO & more), many developed through @CR_UK funded research.

Empowering scientists to acce. 💙
Explore our collection 👉 lnkd.in/emisQFSj

🔬 Ready to capture the complexity of #BladderCancer in your lab?

Its molecular diversity and dynamic tumour microenvironment make translational research challenging.

🧬 At CancerTools.org (@CancerToolsOrg), a non-profit #biorepository offers curated bladder cancer cell ce therapeutic discovery:
✅ MB49 & MB49-Luciferase
✅ UM-UC panel
✅ RT112/84
✅ NCI-HPN lines
👉 Explore now: lnkd.in/eGHZBeqT

🚀 Thrilled to share CancerTools.org has been featured in @SelectScience !
Our very own colleagues, James Ritchie and Natalie Harker reveal how we’re accelerating cancer research to be faster, more accessible & collaborative.
🙏 Thanks to @SelectScience & all advancing this vito/7pfUrvwHS0

💛 September is #ChildhoodCancerAwarenessMonth.
At @CancerToolsOrg (part of @CR_UK), we share research tools worldwide to accelerate discoveries & advance treatments.
Together, we can turn research into impact.
👉 lnkd.in/eesR8BfC

Every tool we equip scientists helps researchers move closer to breakthroughs in ovarian & other gynae cancers.

From lab bench to real-world impact, we stand with @CR_UK & the global research community this #GynaecologicalCancerAwareness Month.

Explore our resources: cancertools.org/research-tools…

Why are more researchers choosing Plasmax™ cell culture medium?

Dr. Sunada Khadka, a former researcher at @MDAndersonNews discovered that using traditional media like DMEM can significantly inflate in vitro drug efficacy.

In her research on ENO1-deleted glioma cells, Sunada ng in vitro drug responses in DMEM, showing notable efficacy and synergy between HEX and CB-839 inhibitors. However, these effects were significantly reduced in vivo, raising concerns with traditional culture media.

The turning point? Using Plasmax™

🔍 With Plasmax™, Sunada uncovered:

➤ Reduced CB-839 toxicity in glioma cells under physiological conditions
➤ Loss of in vitro CB-839 & HEX synergy (previously observed in DMEM)
➤ Evidence that DMEM inflated in vitro drug performance

This case study underscores the importance of media choice in preclinical cancer research. Plasmax™ better replicates the in vivo tumour metabolic environment than traditional media, like DMEM. This supports the generation of more reliable and translatable drug response data.

Read the full case study here ➡️lnkd.in/eQRcsX2m

📍 We’re live at #ADLM2025!

Come visit us at Booth #1762 and meet our dedicated licensing team. Whether you're exploring collaboration opportunities or looking for the right license partner to drive your innovation, we're here to help guide you through the process.

🏢 ion Center
🌐 Chicago, IL. USA
📅 29 - 31 July 2025

We can leverage research tools and technologies developed at @CR_UK and other world-leading cancer institutes, helping you accelerate progress in drug discovery, disease modelling and in-vitro diagnostics.

Let’s connect, discuss your commercial needs, and explore how we can support your journey.

Can't attend the conference? Visit our website to learn more: lnkd.in/eMF4xnzi

#ADLM2025 #LifeSciences #Licensing #CancerResearch #BiotechInnovation #Partnerships #Commercialisation #OncologyResearch #ScientificAdvancements

🌏 World Head and Neck Cancer Day | 27 July  🌏

🔍 Observed annually on July 27th, World Head and Neck Cancer Day raises global awareness of head and neck cancers, highlighting their risk factors and emphasising the critical role of early detection in improving outcomes.

🏢 biorepository, we provide scientists with access to tools developed by leading experts. From cell lines to antibodies, these resources are essential for, drug discovery, and translational research in head and neck cancer.

💫 By making these tools globally accessible, we aim to accelerate scientific discovery and drive innovation in cancer research.

🔗 Discover more at: lnkd.in/ePz2EaR8

We’re thrilled to be joining the scientific community at #ADLM2025 from 27–31 July 2025, hosted @myADLM. Visit us at Booth 1762 to explore our comprehensive collection of cancer research tools, expertly curated to support breakthroughs across academia, biotech, and pharma. g R&D, building new assays, or accelerating preclinical discovery, we work closely with our partners to offer a range of licensing options tailored to your specific needs and the types of tools you wish to access.

✅ Dedicated licensing team of contract and compliance experts.
✅ Access to novel, peer-reviewed tools with commercial potential
✅ Speed up proof of concept and validation
✅ 100% non-profit. 100% focused on cancer.

Let’s connect at #ADLM2025 - Booth 1762 or visit our website to learn more: lnkd.in/eMF4xnzi

#cancerresearch #Oncology

Join us for our free #webinar “Commercialising Research Tools: Increasing the Visibility and Impact of Your Research” organised by CancerTools.org and @FloridaAtlantic

📅 30 October 2024
🕕 10:00am - 11:00am EST (14:00-15:00pm GMT)
💻 Register here: bit.ly/4e8aeIG

#webinar #oncology #cancerresearch #lifesciences #cancerresearcher #cancerscience #genomics #scientificadvancements #cancertoolsorg #oncologyresearch

Bladder cancer remains difficult to treat due to its highly immunosuppressive microenvironment. Effective models are key for advancing research.

The MB49 murine bladder cancer model, used both in vivo and in vitro, has a well-characterised tumour microenvironment and it rapidly ce. It also responds to immune checkpoint inhibitors.

This versatile preclinical tool is used in immuno-oncology to study tumour progression, drug sensitivity, anti-tumour responses, and for therapeutic screening and validation.

Explore our MB49 models, including the luminescent MB49-luc derivative, here: lnkd.in/ePDMzUvh

#bladdercancer #mb49 #cancermodels #bladdercancerresearch #immunology #cancerbiology #oncologyresearch #celllines #tumourmicroenvironment #cancertumourmodels

☀️ We are now live at the @EACRnews Cancer Metabolism Conference in Bilbao.

🗣 Visit us at Stand 4 and discover how for over 40 years, we’ve been facilitating scientists with validated tools in their quest to accelerate cancer research.

⚕ Whether you're a research scientist, n-out, in emerging biotech, or with a large-scale biopharma, our collection of tools can support your efforts to drive innovation and breakthrough discoveries.

🏢 Euskalduna Conference Centre, Bilbao, Spain
📅 08 - 10 October 2024
🕕 09.00am - 17.30pm

Unable to attend? Explore our website to learn more:
cancertools.org/about/

#cancerresearch #cancermetabolism #oncologyresearch #researchincancer #eacrnews #oncology #genomics #drugdiscovery

🚨 ANNOUNCEMENT!!!

📢 We’re thrilled to announce that a selection of popular cancer cell lines, authenticated, validated and widely cited by leading researchers globally, are now solely available at @CancerToolsOrg

🙏 We extend our sincere appreciation to the European ated Cell Cultures (ECACC) for their invaluable support in producing and supplying these critical resources over the past 15 years.

🔮 Explore the range, tailored to your cancer research needs:

💻 Discover more about these research tools on our website:
cancertools.org/popular-cell-l…

#celllines #cancerresearch #lifesciences #oncologyresearch #oncology #breastcancer #ovariancancer #bladdercancer #headandneckcancer #cellcarcinoma #genomics #cancertoolsorg

🧠We’re live at hashtag #CRUKBrain24

⚙ Accelerate your #braintumour research with @CancerToolsOrg. By depositing your research tools with us, you’ll increase their visibility across our website and digital platforms, broadening their reach and making them accessible to a wider nity.

🙋 Meet our experts and discover more! We look forward to seeing you soon!

💻 Unable to attend? Feel free to download our brain cancer deposit leaflet right here: lnkd.in/eW2wkSsr

#braincancerresearch #cancerresearcher #cancerresearchtools #braintumours #lifesciences #events #scientificadvancements #deposityourtool

📅 September is Blood Cancer Awareness Month, the fifth most prevalent cancer in the UK.  As part of @CR_UK , we are determined to accelerate cancer discoveries.

🏢 Our cancer-focused #biorepository provides scientists with access to a collection of research tools such as #PDXmodels, #organoids and more, to accelerate cancer research

These tools specific to blood cancer research include:
➡️ MHYO-LCL2 Human B-lymphoblast Cancer Cell Line:
lnkd.in/ervsq8bU
➡️ JIM 1 & 3 Cell lines: lnkd.in/eWXTkHux
➡️ Anti-CD3 recombinant antibody [UCH-T1TM]: lnkd.in/eifQeh9Q
➡️Anti-Estradiol-17-beta [S16] rAb: lnkd.in/emhjXRdB
➡️ Plus many more

To learn more and explore our full collection of blood cancer research tools, click here.https://lnkd.in/erBxUvun

#bloodcancer #cancerresearch #bloodcancerawarenessmonth
#biorepository #acceleratecancerresearch #bloodcancerresearch
#celllines #antibodies #organoids #pdxmodels
#cancertypes #cancerresearcher #cancerscientist #cruk #bloodcancerresearch

💳 Deposit your research tools with Cancertools.org We are first-of-its-kind non-profit, cancer-focused biorepository

🙋 At CancerTools.org part of @CR_UK, we offer a robust and secure research tool deposit process to the cancer research community including age, production, maintenance, authentication, record keeping and worldwide distribution of research tools.

🌏  Our expert team has worked for more than 40 years with over 180 academic institutes and leading cancer centres globally making their research tools available to the wider scientific community.

💻 Start the process today - its quick and easy - lnkd.in/eF63eUXq

#deposityourtools #cancerresearch #oncologyresearch #oncology #lifesciences #celllines #antibodies #organoids #pdxmodels #smallmolecules #researchers #genomics #scientificadvancements #cancerscience #Technologytransfer #phd #biorepository

🔍Explore a series of 38 new prostate cancer cell lines that accurately reflect the androgen receptor (AR) characteristics of clinical castration-resistant prostate cancer (CRPC). Although most CRPC tumours retain a functional AR that drives tumour growth, preclinical research models.

🔭The standard first-line treatment for advanced prostate cancer is androgen deprivation therapy (ADT). This effectively reduces AR activation, but eventually leads to resistance and CRPC.

💉These new clinically representative cell lines have been developed by Dr. van Weerden and her research team at #ErasmusUniversityMedicalCentre including PC346C cell lines and PTEN-/- Mouse cell lines (MuCap System).

💻Learn more about these cell lines offered by CancerTools here: hubs.la/Q02MSpDs0

#prostatecancer #celllines #crpccelllines #cancerresearch #androgenreceptor #crpc #lifescience #oncology #oncologyresearch #genomics #lifesciences #cancerscience #cellbiology

🔍 Access our Tumour Immunology Antibody Collection

📝 Research in tumour immunology aims to identify new ways of harnessing the power of the immune system to tackle cancer, including developing new immunotherapy treatments, such as immune checkpoint and adoptive T cell 💉CancerTools.org (CancerToolsOrg) has a collection of antibodies that cover key research areas in tumour immunology, including:

✔ Immune cell markers
✔ Immune checkpoints
✔ Tumour-microenvironment
✔ Inflammation
✔ Tumour-intrinsic signalling pathways
✔ Epigenetics

💻 Access our collection here: hubs.la/Q02HBLtJ0 or 📰 Check out our blog for an interesting read
hubs.la/Q02HBHY50

#CancerResearch #Oncology #tumourimmunology #Genomics

📚 : Dysregulation of kinases is a leading cause of oncogenesis and is also implicated in immunological and neurological diseases. There are approximately 518 kinases encoded within the genome, but for over 150 of these, their substrate is unknown - leaving most of the kinome ttle understood with respect to its role in human biology.

✍️To better understand the structure, substrate and function of unstudied kinases, TimWilson from #UniversityofNorthCarolinaatChapelHill and
Structural Genomics Consortium, developed the Kinase Chemogenomic Set.

📄KCGS v2.0 is the most diverse and highly annotated publicly available collection of kinase inhibitors. Cross-screened across hundreds of kinases, the #KCGS set features inhibitors that have met strict selectivity criteria and can be used for cell-based phenotypic screens.

💻Identify high priority ‘dark’ kinases of therapeutic interest and discover new drug targets and diagnostic tools.
Access KCGS here: hubs.la/Q02G2gzr0

#kcgs #cancerresearch #smallmolecules #cancerresearchtools #acceleratecancerresearch #oncology #lifesciences #scientificadvancements #epigenetics #oncologyresearch

July marks #SarcomaAwarenessMonth. Sarcomas are rare cancers that develop in different parts of the body, including the bones and soft tissues.

We work with researchers and scientists who have deposited their research tools to @CancerToolsOrg to support the wider scientific e all forms of cancer research incl. Sarcoma cancer.

Our collection of tools consists of monoclonal antibodies, cell lines, organoids models and more, all readily available to meet your research needs.

Discover more: cancertools.org/?s=sarcoma

#sarcomacancer #sarcomaawarenessmonth #cancerresearch #cancerscience #lifesciences #oncology #bonecancer #bloodcancer #genomic #scientificadvancmentes #researchtools

🔍 Discover the KPC cell lines that were established by Prof Jen Morton's at the @CRUK_SI originating from the KPC mouse model of pancreatic ductal adenocarcinoma (PDA)

📊 They mirror important characteristics found in human PDA, such as pancreatic intraepithelial neoplasia and esponse that results in the exclusion of effector T-cells. Additionally, they maintain the mutations observed in the original murine model.

💻 Access the cell lines here:
cancertools.org/?s=kpc

#kpccelllines #celllines #cancerresearch #lifesciences #oncology #oncologyresearch #murinemodel #pancreaticductaladenocarcinoma

🎗️ #Breastcancer has become a leading cause of cancer-related deaths among female cancer patients due to its high incidence. The impact of breast cancer on women's health has generated significant research interest from scientists worldwide.

➡️ At @cancertoolsorg we are making to cancer research by providing an extensive collection of tools to researchers worldwide.

📚 The collection includes breast cancer #pdx tissues, organoids, mouse models, antibodies, cell culture media and cell lines is supporting cancer scientists to uncover new cancer pathways, develop in vitro cancer models and gain a better understanding of #breastcancer.

💻Discover more at: lnkd.in/eTwYZG7R

#CancerResearch #Oncology #lifesciences

💥 We are thrilled to announce the first established non-tumorigenic mouse melanocyte cell line - Melan-a-cell line is now available from @CancerToolsOrg

⭕ Melan-a cell line, derived from embryonic skin of C57BL mice, is an immortal line of pigmented #melanocytes. It is a g the cellular and molecular aspects of melanoma malignancy, both in vitro and in vivo comparative studies - still being cited 37 years after its original publication, with 387 citations to date. 📑

➤ Key Features:
✅Retains all tested characteristics of normal melanocytes except senescence
✅Immortal and non-tumorigenic in syngeneic or nude mice
✅Diploid chromosome number
✅Syngeneic with C57BL mice and sublines of B16 melanoma
✅Proliferative response to cholera toxin in the presence
of tetradecanoyl phorbol acetate (TPA)

📱 Click here to access the Melan–a cell line: lnkd.in/eDuA_arc

#CancerResearch #Oncology #lifesciences

📘 Expand your research with our antibody collection!

🤝 We have added a range of antibodies deposited by researchers from the @hospital_hvn , a prominent institution part of the @AH_Andalusia , who have been partners of @CancerToolsOrg since April 2023.

🎯These antibodies kers such as CD38, which is a marker for chronic lymphoblastic #leukaemia, and CD16, a NK cell marker, which is being leveraged for its immunotherapy potential.

♾️The collection also includes antibodies for CD42a, CD45R, CD14, and CD9.

Access these antibodies here:
hubs.la/Q02CYPLZ0

#cancerresearch #cancerscience #phd

🎓 MatthewHolley, a former professor at the University of Sheffield has shared insights with us about the GATA3-eGFP reporter cell line, as well as various innovative in vitro models that he has developed throughout his research.

GATA3, a zinc finger transcription factor, plays olling transcription during the processes of development and cell differentiation. The expression level of GATA3 is of utmost importance in various cancer types, as it is closely linked to their progression.

Identifying drugs that can modulate GATA3 expression is of great interest, making a high-throughput screening tool like GATA3-eGFP reporter cell line essential.

GATA3-eGFP reporter cell line expresses GATA3-eGFP via an enhancer that is expressed in a pattern very closely resembling that of native GATA3 during mouse embryonic development.
💻Access the GATA3 cell line: lnkd.in/eFR4cBb9
Or read more of the case study here:
hubs.la/Q02bkf6S0

#cancerresearch #cancerscience #oncology

💥 As we've entered the last day of the 2024 @EACRnews Annual Congress. Yesterday, we had privilege to hear @IlariaMalanchi from @TheCrick deliver an insightful presentation on the difficult balance between tissue regeneration and cancer. 👏

🗣 She discussed how cancer primed stemic regenerative priming in distant organs, an extremely relevant finding for metastasis. Ilaria is one of the many scientists who have contributed research tools to our biorepository to make these available to the wider scientific community.

🤝 Ilaria, together with #LuigiOmbrato, now at @queenmaryuniversity have developed and deposited to CancerTools.org a vector to identify metastatic niche cells by expressing a cancer cell-secreted fluorescent label.

💻 Discover more about this research tools and other on our website:
cancertools.org/?s=Ilaria+Mala…

#cancerresearch #Oncology #cancerscience #scientificadvancments #lifesciences #eacrnews #Cancers

Today, @AlanaWelm from @UUtah gave a talk entitled Patient-derived Models of Breast Cancer for Functional Precision Medicine and Discovery Science.

She discussed today at @EACRnews Annual congress 2024, the bank of 100 #breastcancer #PDX and matched PDxO she developed and how n investigational therapies.

Alana is one of the many scientists who have contributed research tools to @CancerToolsOrg to make these available to the wider scientific community and accelerate cancer discoveries.

These hashtag #PDXs offer a model to study the most aggressive disease subtypes of #breastcancer and will be soon available on our website. Learn more about them and express your interest now!

cancertools.org/?s=pdx

#cancerresearch #cancerscience #oncology #breastcancer #lifescience #phd

We are now live at the @EACRnews Annual Congress 2024! Join us at the @rotterdamahoy !

As part of @CR_UK we are determined to accelerate cancer discoveries and will be showcasing our wide array of research tools as well as discussing potential collaborations.

Visit us at:
📌 am
📅 10 - 13 June 2024
↕ Booth 102
⏲️08.30 - 17.30pm

Unable to attend? View our website for more information.
cancertools.org

@EACRnews #cancerresearch #skincancer #breastcancer #lifesciences #cancerawareness

🥂 The gala dinner at the @PraxisAuril conference last night was exceptional. During the event, Jacob Jaya, PhD delivered a speech on stage, providing an overview of @CancerToolsOrg. Congratulations to Jacob Jaya, PhD Jaya and the entire team on a job well done.

👨The team will booth no 5 until 5pm today. It's not too late to come chat with us and get some cool merchandise!

Unable to make it?
💻 Learn more at cancertools.org

@cancertoolsorg #blackpool #cancerresearch #oncology #lifesciences

✦ We are excited to be join our partner @EACRnews for their annual congress in just under two weeks! We’re looking forward to meeting with @EACRnews members, engaging in discussions on cutting-edge scientific breakthroughs, sharing insights, and developing valuable s at booth 102 to meet and speak with our team and discover a wide array of research tools including cell lines, organoids, and PDX models to support your ongoing cancer research.

🙋We hope to see you there. For more information, visit our website at: hubs.la/Q02yXKjm0

#EACR2024 #cancertoolsorg #cancerresearch #oncology

📅 May is bladder cancer awareness month.

🩸 Bladder cancer is the fourth most diagnosed malignancy cancer.

🔹Transitional cell carcinoma, also known as urothelial carcinoma, is the prevailing form of bladder cancer, originating from cells within the innermost tissue layer of are a researcher or scientist seeking access, we offer a variety of research tools, both for transitional cell carcinoma and other bladder cancer types including the MB49 cell line, that has been widely used for over 45 years to research as well as a suite of UM-UC bladder cancer cell lines.

💻 Access our collection here:
hubs.la/Q02xGX0K0

#cancerawareness #cancer #oncology #lifesciences

🔍Discover our unique suite of A2780 cell lines. The A2780 cell line is a one of the most widely used model within #ovariancancer research.

🕳️Established from an untreated patient with ovarian endometroid adenocarcinoma, this line grows as a monolayer in suspension in spinner enic in immune-deficient mice.

💠Widely used in toxicity testing and cancer genetic studies, its published uses also include the study of tumour neovascularisation resistance to chemotherapeutic drugs and significance of therapeutic targets in ovarian cancer.

💻Find out more information about the A2780 cell line as well as other cell lines that exhibit drug resistance.
hubs.la/Q02xMg9j0

💻 Access the widely used MB49 murine bladder carcinoma cell line on CancerTools.org (CancerToolsOrg).

🔘This line is one of the most established in vitro and in vivo models of urothelial bladder cancer with metastatic potential. It shares pivotal characteristics er and has been widely used for more than 45 years after its original publication by @CRUK researcher, Leonard Franks.

∆Our MB49 derivatives include hashtag#MB49-luc cell line, offering an in vivo readout for tumour take, growth, and reduction.

▷ Click here to access the MB49 cell lines:
hubs.la/Q02vgph-0

#CancerResearch #oncology #lifesciences

🌟 Exciting highlights from @AACR24 🌟:

🎆 Our collection of research tools, deposited by cancer scientists globally, gained immense interest, with a particular focus on our cell lines, organoids and PDX models.

🗣We had several engaging conversations about paediatric and ur merchandise specifically, our research stickers and keyrings were a hit!

👌Finally, it is worth mentioning that AACR's hospitality was exceptional

📱Follow us at @cancertoolsorg for more updates or access our research tool collection here: hubs.la/Q02tLncJ0

#cancertoolsorg #aacr #eventhighlights #cancerresearch #cancer #celllines #researchtools #acceleratecancerresearch #cancertoolsorg #melanoma #pdxmmodels #lifesciences #genomics #scientifcadvancements #americanassociationofcancerresearch #Oncology

🤎 April is #bowelcancerawarenessmonth. Colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases and is the second leading cause of cancer-related deaths worldwide.

💼At CancerTools.org we support discoveries in y making research tools developed from scientists in the field available to the wider scientific community. We curated the first cancer-focused non-profit biorepository of research tools, including cell lines, deposited by universities and cancer institutes worldwide.

💻Access our range of bowel cancer cell lines here:
hubs.la/Q02s_j5W0

🙏Big thanks to @AACR for organising @AACR24 and to all who stopped by to chat with us. It was such an amazing experience meeting other researchers and learning about the latest innovations in #cancerresearch
Until next time 🙋

We are excited to share that we have further strengthened our partnership with @StGeorgesUni and the Functional Genomics Cell Bank in our efforts to accelerate cancer research. Dr. Elena Sviderskaya, the Director of the Functional Genomics Cell Bank at St George's, University of expert in pigment cell and melanoma research. She has developed a set of 68 murine melanocyte and Melan oblast cell lines that are now available through the CancerTools.org

Discover more about Dr. Elena Sviderskaya's cell lines here: hubs.la/Q02sd1WX0

🌟 Fantastic news! - we are officially up and running at the #AACR24 annual meeting.

📬 Stop by stand 1314 to explore our innovative cell line collection comprising of one thousand human and mouse cell lines or speak with one of our experts about depositing your tools. Don't unity!

🎁Get your hands on some of our quirky merchandise and join in on our first ever prize draw! . There is a prize waiting to be won every day for three consecutive days – you could be the lucky winner!

🙋 We look forward to seeing you there!

#AACR24 #events #annualmeeting #genomics #oncology #lifesciences #oncologyresearch #cancerresearch #cancerscience #scientificadvancements